AnVil, Inc., a life sciences discovery company, provides in silico drug discovery and drug development solutions.
AnVil, Inc., a life sciences discovery company, provides in silico drug discovery and drug development solutions. The company specializes in exploring data sets in DNA microarrays, protein microarrays, cheminformatics, screening, and clinical trial data for pharmaceutical, biotechnology, genomics, and proteomics industries. It combines data mining, statistical analysis, and visualization methods to reveal information in data sets from healthcare and health insurance clients. The company also develops algorithms and tools that support the analysis of data, disease identification, and outcome measure definitions. AnVil, Inc. was formerly known as AnVil Informatics.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jan 10, 2001 | Series A | — | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Seaflower Ventures | — | Series A |